10/05/2026
Bayer’s decision wasn’t simply about available land.
The company pointed to Central Ohio’s skilled workforce, growing life-sciences industry and investments in specialized training as major reasons it selected New Albany for its new pharmaceutical manufacturing campus.
The facility is expected to:
• Manufacture pharmaceutical ingredients and finished prescription medications
• Initially support treatments for cancer, cardiovascular disease and kidney disease
• Create approximately 1,500 construction jobs
• Create approximately 600 permanent, high-paying jobs
• Begin pharmaceutical ingredient production in 2031, followed by finished drug manufacturing in 2034
Bayer will join a growing group of life-sciences employers in the New Albany International Business Park, including Amgen, American Regent, Hims & Hers and Pharmavite.
Workforce preparation played a major role in the decision. The new Ohio Life Science Training Center is scheduled to open in New Albany in summer 2027 and will train Ohio workers for advanced biomanufacturing careers.
The impact won’t happen overnight, and one announcement doesn’t automatically determine home values. But an investment of this size can influence job growth, infrastructure, housing demand and future development across northeast Central Ohio.
Do you see this growth as an opportunity for the New Albany area, or are you more concerned about traffic and continued development?